The 20 Best Aphantasia Doctors Near Me in District of Columbia, US

Tesfaye Zelleke is a Pediatric Neurologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 41 years. Dr. Zelleke is rated as an Experienced provider by MediFind in the treatment of Aphantasia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Cortical Dysplasia, and Absence Seizure. Dr. Zelleke is board certified in Clinical Neurophysiology: American Board Of Psychiatry And Neurology, 2011, American Board Of Psychiatry And Neurology, 2009, and Pediatrics: American Board Of Pediatrics, 2004.

Dana Harrar, MD, PhD, is an associate professor of Neurology and Pediatrics at the George Washington University School of Medicine and Health Sciences in Washington, D.C. She serves as the director of the Pediatric Critical Care Neurology Program and Pediatric Stroke Program at Children’s National Hospital. Dr. Harrar cares for patients within the Critical Care Neurology and Intensive Care Unit EEG services. She is board-certified in neurology with special qualifications in child neurology, clinical neurophysiology and neurocritical care. Her research areas of interest include acute pediatric stroke and critical care EEG monitoring. Dr. Harrar is rated as an Experienced provider by MediFind in the treatment of Aphantasia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Seizures, Status Epilepticus, Generalized Tonic-Clonic Seizure, Absence Seizure, and Thrombectomy. Dr. Harrar is board certified in Clinical Neurophysiology: American Board Of Psychiatry And Neurology, 2019 and American Board Of Psychiatry And Neurology, 2016.

Alexandra Wood, MD, is a neurologist at Children’s National Hospital. She is also an assistant professor of neurology and the medical student clerkship co-director at the George Washington University School of Medicine. Dr. Wood graduated from Saint Louis University School of Medicine and completed her residency at the Medical College of Wisconsin. After completing her residency, she worked for two years at the University of Virginia before moving to Washington, D.C., where she practices general child neurology with a special interest in headache. Dr. Wood is passionate about medical education, both of future physicians and for her patients and their families. Her goal at each visit is for the patient and their family to fully understand their diagnosis and treatment plan. Publications: ORCID. Dr. Wood is rated as an Experienced provider by MediFind in the treatment of Aphantasia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Seizures, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Partial Familial Epilepsy, and Memory Loss. Dr. Wood is board certified in American Board Of Psychiatry And Neurology, 2023.

Kuntal Sen, MD, is the co-director of Neurogenetics Clinic in the Division of Neurogenetics and Neurodevelopmental Pediatrics at Children's National Hospital. He is a graduate of Grant Government Medical College, Mumbai. He completed a combined pediatrics-medical genetics and genomics residency at the Detroit Medical Center/Wayne State University of Medicine. He then completed a child neurology fellowship at Children’s National. He also worked at the National Institutes of Health as a volunteer for the Undiagnosed Diseases Program. He is one of the few physicians in the country with dual training in neurology and clinical genetics which affords him a unique expertise to diagnose and manage patients with complex monogenic neurological disorders. Dr. Sen’s clinical expertise is centered on providing long-term, holistic, and family-centered care for patients with mitochondrial diseases and other ultra-rare neuro-metabolic disorders. Dr. Sen's research focus is on multi-modal neuroimaging and neuromonitoring in inborn errors of metabolism. Dr. Sen has published several peer-reviewed articles and presented at many international conferences on newborn screening disorders, rare neurometabolic epilepsies and ethics in genetic testing. Dr. Sen spearheaded a national survey aimed at identifying innovative approaches to educate child neurologists about genomic testing. This initiative culminated in the development and release of a national curriculum through the Child Neurology Society, under his leadership. He was elected chair of the Neurogenetics Section of the American Academy of Neurology, reflecting his national recognition in the field. He is a fellow of the American College of Medical Genetics (ACMG) and a member of the ACMG Advocacy and Government Affairs Committee. He also serves as the media editor for the Pediatric Neurology Journal. During his medical training, he has won awards and grants from professional societies including the prestigious ACMG Foundation/Perkin Elmer Award and Children’s National Founders Auxiliary Board Grant. Publications Google Scholar. Dr. Sen is rated as an Experienced provider by MediFind in the treatment of Aphantasia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Urea Cycle Disorders (UCD), Hydranencephaly, Lissencephaly 2, and Cortical Dysplasia. Dr. Sen is board certified in American Board Of Psychiatry And Neurology, 2022 and Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2019.

Bhavin Dave, MD, is a child and adolescent psychiatrist at Children’s National Hospital in Washington, D.C. He joined the faculty as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences in October 2008, where he was Associate Director of the Infant & Toddler Mental Health Program from November 2008 to March 2020, at which time the Early Childhood Behavior Health Program was founded. As Co-Director of the Early Childhood Behavior Health Program, Dr. Dave’s primary area of focus is with preschool age children and the crucial role of early intervention, working in an innovative, collaborative and team-oriented model with the goal to provide the most comprehensive care possible to young children. His professional interests include collaboration within systems of care, psychoeducation of parents about early mental health and development, and teaching fellows, residents and medical students about preschool emotional and behavioral health. Dr. Dave’s additional roles at Children’s National include Course Director of the Development Seminar Series for first year Child and Adolescent Psychiatry Fellows, Site Supervisor for Saint Elizabeth’s and Howard University 3rd year Adult Psychiatry Residents in the Outpatient Psychiatry Department, Site Coordinator for Elective and Volunteer Observerships for the Department of Psychiatry and Behavioral Sciences and outpatient consultant to the HIV Prevention and Treatment Program. Dr. Dave attended undergraduate at University of Wisconsin-Madison, where he graduated with a double major in molecular biology and English-creative writing. He received his medical degree from the Medical College of Wisconsin in Milwaukee, Wisconsin. He completed his adult psychiatry training at Georgetown University Hospital, including a year as chief resident. He continued his training in the Child and Adolescent Psychiatry training program at the Johns Hopkins Hospital in Baltimore, Maryland, where he also spent one year as chief resident. Dr. Dave has served on the American Association of Child and Adolescent Psychiatry Infant and Preschool and HIV Issues Committees. He is Board Certified in both Child and Adolescent and Adult Psychiatry. Dr. Dave is rated as an Experienced provider by MediFind in the treatment of Aphantasia. His clinical expertise encompasses Autism Spectrum Disorder, Aphantasia, and Attention Deficit Hyperactivity Disorder (ADHD). Dr. Dave is board certified in American Board Of Psychiatry And Neurology, 2010 and Psychiatry: American Board Of Psychiatry And Neurology, 2008.

Wei-Liang Chen, MD, specialized in child neurology and genetics with focus on epilepsy, infantile spasm, brain malformation and other neurodevelopmental disorders. Dr. Chen is in charge of treatment trials in epilepsy. He is the site investigator in a national research consortium, Pediatric Epilepsy Research Consortium (PERC) Infantile Spasm group. He is also the principal investigator for the Epileptic Encephalopathy program at Children's National Hospital and serves as co-investigator in several other research projects focusing on neurogenetic diseases, neurometabolic disorders and functional neuroimaging. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Aphantasia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Megalencephaly-Capillary Malformation Syndrome, Seizures, Epilepsy, and Landau-Kleffner Syndrome. Dr. Chen is board certified in American Board Of Medical Genetics And Genomics, 2021, Clinical Neurophysiology: American Board Of Psychiatry And Neurology, 2019, and Neurology With Special Qualification In Child Neurology: American Board Of Psychiatry And Neurology, 2018.

William D. Gaillard, MD, professor of neurology and neurophysiology, is chief of the Divisions of Child Neurology and of Epilepsy and Neurophysiology. He is director of the Comprehensive Pediatric Epilepsy Program — one of the leading multidisciplinary pediatric epilepsy programs in the country. As associate director of the Children’s National Research Institute’s Center for Neuroscience Research, he is responsible for overseeing and organizing clinical neuroscience research. Dr. Gaillard is professor of pediatrics and neurology at the George Washington University School of Medicine; Professor of Neurology, Georgetown University; and Adjunct Professor of Hearing and Speech Sciences, University of Maryland, College Park. Additionally, Dr. Gaillard holds longstanding collaborations with the Clinical Epilepsy Section (CES), National Institute of Neurological Disorders and Stroke and NIH. His innovative research utilizes advanced structural and functional imaging to examine the effects of epilepsy on brain structure and function. His pioneering work with functional imaging has changed clinical practice for patients with epilepsy, made important technical contributions to structural and functional imaging methods, and provided fundamental scientific insights on the biology of brain plasticity. Ultimately, the goal of his research is to improve the outcomes and lives of children with epilepsy. Dr. Gaillard is a past president of the American Epilepsy Society. He is past treasurer of the American Epilepsy Society, past chair of the International League Against Epilepsy (ILAE) Commission on Diagnostics, past chair of the ILAE Pediatric Epilepsy Surgery Task Force and past member of the Pediatric Commission. He is a past editor of Epilepsy Research and a past editor of Epilepsia. He is the author of more than 240 peer-reviewed scientific papers and more than 50 chapters and holds longstanding federal and foundation grant funding. Dr. Gaillard is rated as an Experienced provider by MediFind in the treatment of Aphantasia. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Status Epilepticus, Liver Embolization, and Deep Brain Stimulation. Dr. Gaillard is board certified in American Board Of Psychiatry And Neurology, Pediatrics: American Board Of Pediatrics, 2005, and American Board Of Psychiatry And Neurology, 1992.

Marc DiFazio, MD, is the vice president of Access at Children’s National Hospital and is certified in adult and pediatric neurology. He completed his pediatric and neurology training at Walter Reed Army Medical Center, and went on to become the chief of the Child Neurology Service at Walter Reed, where he served on active duty until 2005 before transitioning to private practice in Rockville, MD. Dr. DiFazio is well-known in the metropolitan area and pediatric community for his service, leadership and expertise in clinical child neurology, with interests and concentration in the areas of Tourette syndrome, headache/migraine, concussion, behavioral neurology/autism and the use of botulinum toxin in a variety of conditions. In his role as vice president of Access, Dr. DiFazio works to facilitate patient access to care and supporting operational excellence. Dr. DiFazio has served 28 years in the Army Medical Corps, and he recently finished his service obligation in his final assignment as Command Surgeon of USAR Legal Command. Dr. Difazio is rated as an Experienced provider by MediFind in the treatment of Aphantasia. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Benign Rolandic Epilepsy, Tourette Syndrome, Cerebral Palsy, and Landau-Kleffner Syndrome. Dr. Difazio is board certified in Epilepsy: American Board Of Psychiatry And Neurology, 2018, Neurology With Special Qualification In Child Neurology: American Board Of Psychiatry And Neurology, 2001, and Pediatrics: American Board Of Pediatrics, 1994.

Jeffery Strelzik, MD, was born and raised in Atlanta, GA. He attended the University of Maryland, College Park, where he earned undergraduate degrees in psychology and neurobiology/physiology and attended medical school at the Medical College of Georgia in Augusta, GA. He completed his child neurology residency at Children’s National Hospital in Washington, D.C. He is an assistant professor of neurology and pediatrics and the associate program director of the Child Neurology Residency Program at Children’s National Hospital. Dr. Strelzik has a clinical and research focus in pediatric headaches and concussions, and an enthusiasm for neurogenetics. He is the director of the Headache Injection Program and director of the Outpatient Headache Infusion Program. Dr. Strelzik is also a founding member of the Interdisciplinary Concussion Care Clinic at Children’s National. He completed the Master Teacher Leadership Development Program and has a strong interest in medical education. Dr. Strelzik has general child neurology clinics and headache clinics in Friendship Heights, Prince George's County and the Main Hospital. Dr. Strelzik is rated as an Experienced provider by MediFind in the treatment of Aphantasia. His clinical expertise encompasses Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Seizures, Wolf-Hirschhorn Syndrome, and Partial Seizure. Dr. Strelzik is board certified in American Board Of Psychiatry And Neurology, 2018.

Juma Mbwana, MD, joins Children's National Hospital from the Children's Hospital of Philadelphia. He is a graduate of Yale College with a B.S. in biomedical engineering and the Morehouse School of Medicine. He completed training in pediatrics at the Yale-New Haven Hospital as well as training in adult and child neurology at the University of Pennsylvania and the Children's Hospital of Philadelphia (CHOP). At the completion of his training at CHOP, Dr. Mbwana was given the Meg Olivia Barkman Award, an annual award that recognizes neurology residents who demonstrate clinical excellence and a compassionate approach to care. Dr. Mbwana's research interests include projects that utilize biomedical engineering innovations and emerging technologies for clinical neuroscience advancement. Having lived in the Middle East and Africa in childhood, Dr. Mbwana has a personal interest in global health issues and during his pediatric residency, he participated in the Yale Pediatric Refugee Clinic. He enjoys gardening and spending time outdoors. Dr. Mbwana is rated as an Experienced provider by MediFind in the treatment of Aphantasia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Absence Seizure, and Epilepsy in Children. Dr. Mbwana is board certified in American Board Of Psychiatry And Neurology, 2017.

John M. Schreiber, MD, FAES, is the Associate Chief of Epilepsy and EEG Operations, Medical Director of EEG and the Epilepsy Monitoring Unit and the director of Epilepsy Genetics at Children's National Hospital. After earning his medical degree cum laude at the University of Maryland School of Medicine, he completed Pediatrics and Child Neurology training at Children’s National Hospital. Before returning in 2013, he served as an Epilepsy and Clinical Neurophysiology Fellow at the National Institutes of Health, gaining experience in epilepsy clinical trials and in neurogenetic disorders. His primary clinical and research interests are on the diagnosis, evaluation and treatment of genetically-mediated epilepsies, particularly channelopathies. Dr. Schreiber is the principal investigator at Children’s National for various epilepsy observational and interventional clinical trials with a focus on neurogenetic disorders. He serves on the Pediatric Epilepsy Research Consortium board, is the co-chair for the Investigators' Workshop Committee of the American Epilepsy Society, and serves on the Epilepsy Foundation Professional Advisory Board and several other advisory boards. Publications PUBMED. Dr. Schreiber is rated as an Experienced provider by MediFind in the treatment of Aphantasia. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Myoclonic Epilepsy, Seizures, and Epilepsy with Myoclonic-Atonic Seizures. Dr. Schreiber is board certified in Epilepsy: American Board Of Psychiatry And Neurology, 2016, American Board Of Psychiatry And Neurology, 2013, and American Board Of Psychiatry And Neurology, 2011.